These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38012287)

  • 1. In vivo reprogramming leads to premature death linked to hepatic and intestinal failure.
    Parras A; Vílchez-Acosta A; Desdín-Micó G; Picó S; Mrabti C; Montenegro-Borbolla E; Maroun CY; Haghani A; Brooke R; Del Carmen Maza M; Rechsteiner C; Battiston F; Branchina C; Perez K; Horvath S; Bertelli C; Sempoux C; Ocampo A
    Nat Aging; 2023 Dec; 3(12):1509-1520. PubMed ID: 38012287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial in vivo reprogramming enables injury-free intestinal regeneration via autonomous
    Kim J; Kim S; Lee SY; Jo BK; Oh JY; Kwon EJ; Kim KT; Adpaikar AA; Kim EJ; Jung HS; Kim HR; Roe JS; Hong CP; Kim JK; Koo BK; Cha HJ
    Sci Adv; 2023 Nov; 9(47):eadi8454. PubMed ID: 38000027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of Fibrosis and Scar Formation by Partial Reprogramming In Vivo.
    Doeser MC; Schöler HR; Wu G
    Stem Cells; 2018 Aug; 36(8):1216-1225. PubMed ID: 29761584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous expression of reprogramming factors induces and maintains mouse pluripotency without specific growth factors and signaling inhibitors.
    Mao Y; Wang L; Zhong B; Yang N; Li Z; Cui T; Feng G; Li W; Zhang Y; Zhou Q
    Cell Prolif; 2021 Aug; 54(8):e13090. PubMed ID: 34197016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roadmap of the Early Events of
    Guallar D
    Cell Reprogram; 2023 Feb; 25(1):7-8. PubMed ID: 36695734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming.
    Chondronasiou D; Gill D; Mosteiro L; Urdinguio RG; Berenguer-Llergo A; Aguilera M; Durand S; Aprahamian F; Nirmalathasan N; Abad M; Martin-Herranz DE; Stephan-Otto Attolini C; Prats N; Kroemer G; Fraga MF; Reik W; Serrano M
    Aging Cell; 2022 Mar; 21(3):e13578. PubMed ID: 35235716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of apoptosis gene loci by reprogramming factors leads to selective eradication of leukemia cells.
    Wang Y; Lu T; Sun G; Zheng Y; Yang S; Zhang H; Hao S; Liu Y; Ma S; Zhang H; Ru Y; Gao S; Yen K; Cheng H; Cheng T
    Nat Commun; 2019 Dec; 10(1):5594. PubMed ID: 31811153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles of Cyclin D1 in mouse embryonic fibroblast cell reprogramming.
    Oh HR; Kim J; Kim J
    FEBS J; 2016 Dec; 283(24):4549-4568. PubMed ID: 27790870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
    Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
    Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.
    Mosteiro L; Pantoja C; Alcazar N; Marión RM; Chondronasiou D; Rovira M; Fernandez-Marcos PJ; Muñoz-Martin M; Blanco-Aparicio C; Pastor J; Gómez-López G; De Martino A; Blasco MA; Abad M; Serrano M
    Science; 2016 Nov; 354(6315):. PubMed ID: 27884981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interplay of chromatin and transcription factors during cell fate transitions in development and reprogramming.
    Peñalosa-Ruiz G; Bright AR; Mulder KW; Veenstra GJC
    Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194407. PubMed ID: 31356991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation.
    Lehmann M; Canatelli-Mallat M; Chiavellini P; Cónsole GM; Gallardo MD; Goya RG
    Curr Gene Ther; 2019; 19(4):248-254. PubMed ID: 31475896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo reprogramming for tissue regeneration and organismal rejuvenation.
    Taguchi J; Yamada Y
    Curr Opin Genet Dev; 2017 Oct; 46():132-140. PubMed ID: 28779646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejuvenation by Partial Reprogramming of the Epigenome.
    Mendelsohn AR; Larrick JW; Lei JL
    Rejuvenation Res; 2017 Apr; 20(2):146-150. PubMed ID: 28314379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient transcription factor (OSKM) expression is key towards clinical translation of
    de Lázaro I; Cossu G; Kostarelos K
    EMBO Mol Med; 2017 Jun; 9(6):733-736. PubMed ID: 28455313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.
    Ocampo A; Reddy P; Martinez-Redondo P; Platero-Luengo A; Hatanaka F; Hishida T; Li M; Lam D; Kurita M; Beyret E; Araoka T; Vazquez-Ferrer E; Donoso D; Roman JL; Xu J; Rodriguez Esteban C; Nuñez G; Nuñez Delicado E; Campistol JM; Guillen I; Guillen P; Izpisua Belmonte JC
    Cell; 2016 Dec; 167(7):1719-1733.e12. PubMed ID: 27984723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Safer Path to Cellular Rejuvenation: Endogenous Oct4 Activation via CRISPR/dCas9 in Progeria Mouse Models.
    Hu D; Borgne EL; Meinl R
    Cell Reprogram; 2023 Aug; 25(4):136-138. PubMed ID: 37327373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.
    Maza I; Caspi I; Zviran A; Chomsky E; Rais Y; Viukov S; Geula S; Buenrostro JD; Weinberger L; Krupalnik V; Hanna S; Zerbib M; Dutton JR; Greenleaf WJ; Massarwa R; Novershtern N; Hanna JH
    Nat Biotechnol; 2015 Jul; 33(7):769-74. PubMed ID: 26098448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a dynamic gene regulatory network required for pluripotency factor-induced reprogramming of mouse fibroblasts and hepatocytes.
    Papathanasiou M; Tsiftsoglou SA; Polyzos AP; Papadopoulou D; Valakos D; Klagkou E; Karagianni P; Pliatska M; Talianidis I; Agelopoulos M; Thanos D
    EMBO J; 2021 Jan; 40(1):e102236. PubMed ID: 33034061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.